alpha-aminopyridine has been researched along with Waldenstrom Macroglobulinemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KC; Baloglu, E; Fulciniti, M; Hunter, Z; Kumar, S; Li, N; Linares, M; Lopez, MA; Martinez-Lopez, J; Munshi, NC; Oliva, S; Perini, T; Senapedis, W; Shammas, MA; Treon, SP; Xu, L; Xu, Y | 1 |
| Azab, AK; Azab, F; Ghobrial, IM; Glavey, SV; Manier, S; Mishima, Y; Moschetta, M; Roccaro, AM; Sacco, A; Sahin, I; Tsang, B; Zhang, Y | 1 |
| Ansell, SM; Baladandayuthapani, V; Bjorklund, CC; Jones, RJ; Kuiatse, I; Lin, HY; Orlowski, RZ; Shah, JJ; Thomas, SK; Treon, SP; Wang, M; Weber, DM; Yang, G; Zhang, XD | 1 |
3 other study(ies) available for alpha-aminopyridine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia.
Topics: Acrylamides; Aminopyridines; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokines; DNA Breaks, Double-Stranded; DNA Damage; Gene Expression Regulation, Neoplastic; Humans; Nicotinamide Phosphoribosyltransferase; p21-Activated Kinases; Rad51 Recombinase; Waldenstrom Macroglobulinemia | 2019 |
Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Cycle; Cell Line; Cell Line, Tumor; Chemotaxis; Coculture Techniques; Drug Screening Assays, Antitumor; Female; Fibronectins; Humans; Mesenchymal Stem Cells; Mice; Mice, SCID; Morpholines; Multiple Myeloma; Neoplasm Invasiveness; Neoplasm Proteins; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Receptors, CXCR4; RNA Interference; RNA, Small Interfering; Waldenstrom Macroglobulinemia; Xenograft Model Antitumor Assays | 2014 |
Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia.
Topics: Aminopyridines; Apoptosis; B-Lymphocytes; Cell Cycle; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Morpholines; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Signal Transduction; Syk Kinase; Waldenstrom Macroglobulinemia | 2015 |